Safety, Tolerability, and Efficacy of Doxorubicin and Pembrolizumab for Sarcoma
Condition(s):Soft Tissue Sarcoma, Adult; Soft Tissue Sarcoma, ChildLast Updated:November 18, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Soft Tissue Sarcoma, Adult; Soft Tissue Sarcoma, ChildLast Updated:November 18, 2023Completed
Condition(s):Breast CancerLast Updated:February 16, 2023Recruiting
Condition(s):Advanced Soft-tissue Sarcoma; Metastatic Soft-tissue SarcomaLast Updated:June 22, 2023Recruiting
Condition(s):LeiomyosarcomaLast Updated:October 10, 2023Recruiting
Condition(s):LymphomaLast Updated:March 17, 2021Unknown status
Condition(s):Cancer of LiverLast Updated:October 22, 2018Completed
Condition(s):Recurrent Ovarian CancerLast Updated:January 26, 2016Completed
Condition(s):Endometrial CancerLast Updated:August 22, 2014Terminated
Condition(s):Breast CancerLast Updated:June 6, 2016Unknown status
Condition(s):Epithelial Ovarian CancerLast Updated:December 17, 2015Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.